Public Policy Letters, Statements, Legal Briefs, & Other Responses
← Back to all Letters & Statements
-
ACMG Comments to EEOC Concerning Proposed Rule Related to the Genetic Information Nondiscrimination Act (GINA)
-
ACMG Comments to OHRP Concerning Proposed Revisions to the Common Rule
-
ACMG Response to Expansion of Direct-to-Consumer Genetic Testing
-
ACMG Testimony in Support of the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Response to FDA’s Proposed Regulatory Framework for LDTs
-
ACMG One-Pager on FDA’s Proposed Regulatory Framework for LDTs
-
ACMG Letter to Congress Supporting the Accurate Education for Prenatal Screenings Act (HR 3441)
-
ACMG Comments to EEOC Concerning Regulations Under the Americans with Disabilities Act (ADA)
-
ACMG Comments to FDA Concerning the FDA Draft Guidance on the Framework for Regulatory Oversight of LDTs
-
ACMG Comments to FDA Concerning the FDA Draft Guidance on Notification and Medical Device Reporting for LDTs